Dexamethasone - oral dissolvable film - AcuCort

Drug Profile

Dexamethasone - oral dissolvable film - AcuCort

Alternative Names: Dexa-ODF

Latest Information Update: 26 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator AcuCort
  • Class Anti-inflammatories; Antiemetics; Antineoplastics; Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Unspecified
  • Clinical Phase Unknown Chemotherapy-induced nausea and vomiting; Croup; Hypersensitivity

Most Recent Events

  • 26 Mar 2018 Chemical structure information added
  • 20 Feb 2018 The EU approval for marketing the drug is expected in 2019 (AcuCort website)
  • 20 Feb 2018 The US FDA approval for marketing the drug is expected in 2020 (AcuCort website)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top